News Image

Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate

Provided By PR Newswire

Last update: Sep 8, 2025

Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation

Read more at prnewswire.com

ICECURE MEDICAL LTD

NASDAQ:ICCM (12/16/2025, 8:00:02 PM)

After market: 0.6323 +0.01 (+1.05%)

0.6257

-0.01 (-2.23%)



Find more stocks in the Stock Screener

Follow ChartMill for more